• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性性别不是分化型甲状腺癌复发的独立危险因素:一项倾向评分匹配研究。

Male sex is not an independent risk factor for recurrence of differentiated thyroid cancer: a propensity score-matching study.

机构信息

Department of Surgery, College of Medicine, The Catholic University of Korea, 06591, Seoul, Republic of Korea.

Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, 06591, Seoul, Republic of Korea.

出版信息

Sci Rep. 2021 Jul 21;11(1):14908. doi: 10.1038/s41598-021-94461-5.

DOI:10.1038/s41598-021-94461-5
PMID:34290341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8295365/
Abstract

Male patients have a significantly higher prevalence of advanced-stage thyroid cancer. However, sex differences in the risk of differentiated thyroid carcinoma (DTC) recurrence have not been fully elucidated. Therefore, the present study aimed to investigate male sex as a prognostic factor for DTC. We assessed 5566 patients with DTC who underwent thyroid surgery between January 2009 and December 2015 at Seoul St. Mary's Hospital (Seoul, Korea). Clinicopathological characteristics and long-term oncologic outcomes between female and male patients with DTC were compared using propensity score matching to reduce selection bias. The mean follow-up duration was 99.9 ± 18.7 months. The recurrence rate was significantly higher in male patients than female patients before matching (3.3% vs. 2.2%, p = 0.030), and there was no significant difference in recurrence rates between the matched groups after matching (3.0% vs. 2.5%, p = 0.591). Based on Kaplan-Meier analysis, the two groups did not significantly differ in disease-free survival after matching. Multivariate analysis revealed that male sex was not an independent prognostic factor of DTC recurrence. Male sex did not have a significant effect on DTC recurrence. Further studies with larger cohorts are required to validate the findings of this study.

摘要

男性患者甲状腺癌晚期的患病率明显更高。然而,性别差异对分化型甲状腺癌(DTC)复发风险的影响尚未完全阐明。因此,本研究旨在探讨男性性别作为 DTC 的预后因素。我们评估了 2009 年 1 月至 2015 年 12 月期间在韩国首尔圣玛丽医院接受甲状腺手术的 5566 例 DTC 患者。使用倾向评分匹配来减少选择偏差,比较女性和男性 DTC 患者的临床病理特征和长期肿瘤学结果。平均随访时间为 99.9 ± 18.7 个月。在匹配前,男性患者的复发率明显高于女性患者(3.3%比 2.2%,p=0.030),匹配后两组的复发率无显著差异(3.0%比 2.5%,p=0.591)。基于 Kaplan-Meier 分析,匹配后两组的无病生存率无显著差异。多因素分析显示,男性性别不是 DTC 复发的独立预后因素。男性性别对 DTC 复发没有显著影响。需要更大队列的进一步研究来验证本研究的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396d/8295365/d049b489a498/41598_2021_94461_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396d/8295365/e5b6476b45d3/41598_2021_94461_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396d/8295365/d049b489a498/41598_2021_94461_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396d/8295365/e5b6476b45d3/41598_2021_94461_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396d/8295365/d049b489a498/41598_2021_94461_Fig2_HTML.jpg

相似文献

1
Male sex is not an independent risk factor for recurrence of differentiated thyroid cancer: a propensity score-matching study.男性性别不是分化型甲状腺癌复发的独立危险因素:一项倾向评分匹配研究。
Sci Rep. 2021 Jul 21;11(1):14908. doi: 10.1038/s41598-021-94461-5.
2
Comparison of long-term surgical outcome between transaxillary endoscopic and conventional open thyroidectomy in patients with differentiated thyroid carcinoma: a propensity score matching study.经腋窝内镜甲状腺切除术与传统开放性甲状腺切除术治疗分化型甲状腺癌的长期手术结局比较:一项倾向评分匹配研究。
Surg Endosc. 2021 Jun;35(6):2855-2861. doi: 10.1007/s00464-020-07721-2. Epub 2020 Jun 15.
3
Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.根据甲状腺切除术的范围,1 至 4 厘米分化型甲状腺癌患者的肿瘤学结果。
Head Neck. 2019 Jan;41(1):56-63. doi: 10.1002/hed.25356. Epub 2018 Dec 10.
4
Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.21岁以下分化型甲状腺癌患者复发的预测因素及当前文献的荟萃分析
Tumour Biol. 2016 Jun;37(6):7797-808. doi: 10.1007/s13277-015-4532-6. Epub 2015 Dec 22.
5
Oncologic outcomes of robotic thyroidectomy: 5-year experience with propensity score matching.机器人甲状腺切除术的肿瘤学结局:倾向评分匹配的5年经验
Surg Endosc. 2016 Nov;30(11):4785-4792. doi: 10.1007/s00464-016-4808-y. Epub 2016 Feb 19.
6
The association between vitamin D supplementation and the long-term prognosis of differentiated thyroid cancer patients: a retrospective observational cohort study with propensity score matching.维生素 D 补充与分化型甲状腺癌患者长期预后的关系:一项基于倾向评分匹配的回顾性观察性队列研究。
Front Endocrinol (Lausanne). 2023 Jun 13;14:1163671. doi: 10.3389/fendo.2023.1163671. eCollection 2023.
7
Prognosis of papillary thyroid cancer in patients with Graves' disease: a propensity score-matched analysis.Graves 病合并甲状腺乳头状癌患者的预后:倾向评分匹配分析。
World J Surg Oncol. 2020 Oct 13;18(1):266. doi: 10.1186/s12957-020-02044-x.
8
Risk for Thyroid Cancer Recurrence Is Higher in Men Than in Women Independent of Disease Stage at Presentation.男性甲状腺癌复发的风险高于女性,与疾病的初始分期无关。
Thyroid. 2020 Jun;30(6):871-877. doi: 10.1089/thy.2018.0775. Epub 2019 Nov 13.
9
Multifocality Is not an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score-Matching Analysis.多灶性不是甲状腺乳头状癌的独立预后因素:倾向评分匹配分析。
Thyroid. 2019 Apr;29(4):513-522. doi: 10.1089/thy.2018.0547. Epub 2019 Mar 15.
10
Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging F-FDG PET/CT.通过重新分期的F-FDG PET/CT评估分化型甲状腺癌、甲状腺球蛋白升高且I-131全身扫描阴性患者复发的危险因素及分层
Hell J Nucl Med. 2016 Sep-Dec;19(3):208-217. doi: 10.1967/s002449910402. Epub 2016 Nov 8.

引用本文的文献

1
Global, regional, and national burden of thyroid cancer in women of child-bearing age, 1990 to 2021 and predictions to 2035: An analysis of the global burden of disease study 2021.1990年至2021年以及到2035年的预测:全球疾病负担研究2021对育龄期女性甲状腺癌的全球、区域和国家负担分析
Front Endocrinol (Lausanne). 2025 Jun 27;16:1555841. doi: 10.3389/fendo.2025.1555841. eCollection 2025.
2
EFFICACY AND PROGNOSIS IN PATIENTS WITH PAPILLARY THYROID CANCER WITH POSTOPERATIVE PREABLATIVE STIMULATED THYROGLOBULIN ABOVE 10 NG/ML AFTER INITIAL THERAPY WITH RADIOIODINE.初始接受放射性碘治疗后,术后消融前刺激甲状腺球蛋白高于10 ng/ml的乳头状甲状腺癌患者的疗效及预后
Acta Endocrinol (Buchar). 2024 Apr-Jun;20(2):186-192. doi: 10.4183/aeb.2024.186. Epub 2025 Jan 18.
3

本文引用的文献

1
Comparison of long-term prognosis for differentiated thyroid cancer according to the 7th and 8th editions of the AJCC/UICC TNM staging system.根据美国癌症联合委员会(AJCC)/国际抗癌联盟(UICC)第7版和第8版TNM分期系统对分化型甲状腺癌长期预后的比较。
Ther Adv Endocrinol Metab. 2020 May 19;11:2042018820921019. doi: 10.1177/2042018820921019. eCollection 2020.
2
Thyroid Carcinoma: Do We Need to Treat Men and Women Differently?甲状腺癌:我们需要对男性和女性区别对待吗?
Visc Med. 2020 Feb;36(1):10-14. doi: 10.1159/000505496. Epub 2020 Jan 14.
3
Risk for Thyroid Cancer Recurrence Is Higher in Men Than in Women Independent of Disease Stage at Presentation.
Consider or not consider: the unsolved question on the use of radioactive iodine for differentiated thyroid cancer with low to intermediate risk of recurrence.考虑还是不考虑:关于放射性碘在复发风险低至中度的分化型甲状腺癌治疗中的未解决问题。
Endocrine. 2025 Feb;87(2):658-666. doi: 10.1007/s12020-024-04027-4. Epub 2024 Sep 26.
4
Unexpected Tc-pertechnetate avidity of lymph node metastases predicts better response to radioiodine therapy in differentiated thyroid cancer patients with lymph node metastases.分化型甲状腺癌伴淋巴结转移患者中,淋巴结转移灶意外摄取高锝酸盐预示着对放射性碘治疗有更好的反应。
Am J Nucl Med Mol Imaging. 2024 Feb 20;14(1):63-71. doi: 10.62347/PBCV5827. eCollection 2024.
5
Relationship of Recurrence Rate with some Characteristics in Patients with Thyroid Carcinoma.甲状腺癌患者复发率与某些特征的关系
Indian J Endocrinol Metab. 2023 Nov-Dec;27(6):544-551. doi: 10.4103/ijem.ijem_134_23. Epub 2024 Jan 11.
6
Risk Stratification of Differentiated Thyroid Cancer at King Abdullah Specialized Children's Hospital Endocrinology Clinic in Riyadh, Saudi Arabia.沙特阿拉伯利雅得阿卜杜拉国王专科医院内分泌诊所分化型甲状腺癌的风险分层
Cureus. 2023 Dec 30;15(12):e51372. doi: 10.7759/cureus.51372. eCollection 2023 Dec.
7
Risk factors for recurrent disease in small papillary thyroid cancers - a Swedish register-based study.小乳头状甲状腺癌复发的风险因素 - 一项瑞典基于登记的研究。
Langenbecks Arch Surg. 2023 Apr 26;408(1):162. doi: 10.1007/s00423-023-02905-5.
8
Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis.甲状腺外微小侵犯对分化型甲状腺癌术后复发风险的影响:一项回顾性分析。
J Endocrinol Invest. 2023 Oct;46(10):2157-2164. doi: 10.1007/s40618-023-02070-y. Epub 2023 Mar 28.
9
Extrathyroidal extension and cervical node infiltration are associated with recurrences and shorter recurrence-free survival in differentiated thyroid cancer: a cohort study.甲状腺外扩展和颈部淋巴结浸润与分化型甲状腺癌的复发及较短的无复发生存期相关:一项队列研究。
Thyroid Res. 2022 Jul 26;15(1):13. doi: 10.1186/s13044-022-00131-7.
10
A Prognostic Model of Differentiated Thyroid Cancer Based on Up-Regulated Glycolysis-Related Genes.基于上调的糖酵解相关基因的分化型甲状腺癌预后模型。
Front Endocrinol (Lausanne). 2022 Apr 22;13:775278. doi: 10.3389/fendo.2022.775278. eCollection 2022.
男性甲状腺癌复发的风险高于女性,与疾病的初始分期无关。
Thyroid. 2020 Jun;30(6):871-877. doi: 10.1089/thy.2018.0775. Epub 2019 Nov 13.
4
Current trends in the features of male thyroid cancer: Retrospective evaluation of their prognostic value.男性甲状腺癌特征的当前趋势:对其预后价值的回顾性评估。
Medicine (Baltimore). 2019 May;98(19):e15559. doi: 10.1097/MD.0000000000015559.
5
Prognosis of Differentiated Thyroid Carcinoma with Initial Distant Metastasis: A Multicenter Study in Korea.初发远处转移的分化型甲状腺癌的预后:韩国的一项多中心研究
Endocrinol Metab (Seoul). 2018 Jun;33(2):287-295. doi: 10.3803/EnM.2018.33.2.287.
6
Multifocality as a prognostic factor in thyroid cancer: A meta-analysis.多灶性作为甲状腺癌的预后因素:一项荟萃分析。
Int J Surg. 2018 Feb;50:121-125. doi: 10.1016/j.ijsu.2017.12.035. Epub 2018 Jan 11.
7
Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study.韩国分化型甲状腺癌患者的疾病特异性死亡率:一项多中心队列研究。
Endocrinol Metab (Seoul). 2017 Dec;32(4):434-441. doi: 10.3803/EnM.2017.32.4.434. Epub 2017 Nov 22.
8
The 2017 Bethesda System for Reporting Thyroid Cytopathology.2017 年甲状腺细胞病理学报告的贝塞斯达系统。
Thyroid. 2017 Nov;27(11):1341-1346. doi: 10.1089/thy.2017.0500.
9
Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5.86690例甲状腺癌患者的生存情况:一项基于欧洲癌症研究与治疗组织(EUROCARE)-5中29个欧洲国家人群的研究。
Eur J Cancer. 2017 May;77:140-152. doi: 10.1016/j.ejca.2017.02.023. Epub 2017 Apr 11.
10
Is Male Gender a Prognostic Factor for Papillary Thyroid Microcarcinoma?男性性别是甲状腺微小乳头状癌的一个预后因素吗?
Ann Surg Oncol. 2017 Jul;24(7):1958-1964. doi: 10.1245/s10434-017-5788-4. Epub 2017 Jan 27.